Low-income children with diabetes do better in Ontario than in California B.C. medicare challenge: health-care economist says regulations can prevent adverse effects of expanding private financing 5 tips for enhancing adherence in patients with mental illness Important tips pharmacists can adopt to maximize adherence in patients with mental illness. ‘Zombie’ outbreak linked to synthetic cannabinoid Herbal product blamed for mass intoxication in New York last July OMA 'outraged' by Dr. Eric Hoskins' public fee deal proposal In a press scrum, the Ontario health minister said he wanted to give the OMA more time to consider the proposal but added that they couldn't 'wait forever' CPhA applauds pot task force report Document says government should be open to pharmacy distribution of medicinal cannabis if legalizing recreational use compromises access. Clinical Feature: Loperamide misuse Take steps to identify patients at risk, minimize harm and prevent misuse. Neither private nor public healthcare system a cure-all, health economist testifies Chlorpropamide to be discontinued in Canada before mid-2017 Patients taking chlorpropamide must be switched to an alternate therapy for type 2 diabetes. Bill 130 riles family doctors in Quebec First Previous 1240 1241 1242 1243 1244 Next Last